info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » healthcare

Healthcare

Pancreatic Cancer Treatment Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiotherapy, Others); By Disease Stage (Localized, Locally Advanced, Metastatic); By End User (Hospitals & Cancer Centers, Specialty Clinics, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pancreatic Cancer Treatment Market will witness a robust CAGR of 11.8% , valued at USD 6.4 billion in 2024 , expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485

Anterior Uveitis Treatment Market By Treatment Type (Corticosteroids, Cycloplegics, Biologics, Immunosuppressants, NSAIDs); By Route of Administration (Topical, Oral, Parenteral, Implants); By End User (Hospitals, Specialty Clinics, ASCs, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anterior Uveitis Treatment Market will witness a robust CAGR of 6.9% , valued at $494.7 million in 2024 , expected to appreciate and reac... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Gastroesophageal Reflux Disease (GERD) Therapeutics Market Gastroesophageal Reflux Disease Therapeutics Market By Drug Class (PPIs, H2 Receptor Antagonists, Antacids, Prokinetics, Mucosal Protectants); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market is projected to grow at a robust CAGR of 5.7% , increasing from USD 7.... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Inflammatory Bowel Disease (IBD) Treatment Market By Drug Class (Biologics [TNF-alpha Inhibitors, Integrin Inhibitors, Interleukin Inhibitors], Small Molecules [JAK Inhibitors, S1P Receptor Modulators], 5-ASA Derivatives, Corticosteroids, Immunomodulators, Others); By Disease Type (Crohn’s Disease, Ulcerative Colitis); By Route of Administration (Oral, Injectable, Rectal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Inflammatory Bowel Disease (IBD) Treatment Market will witness a robust CAGR of 6.9% , valued at $24.8 billion in 2024 ,... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Spheroids Market By Technology Type (Scaffold-Based, Scaffold-Free); By Application (Cancer Research, Drug Discovery & Toxicology Testing, Stem Cell Research, Regenerative Medicine, Tissue Engineering); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs, Hospitals & Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Spheroids Market will witness a robust CAGR of 18.3% , valued at $802 million in 2024, and is expected to reach nearly $2.18 billion by 2030 , confirms St... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Small Molecule API Market By Type (Innovative APIs, Generic APIs); By Manufacturing Method (In-house, Outsourced); By Therapeutic Application (Oncology, Cardiovascular, CNS, Infectious Diseases, Respiratory, Diabetes, Others); By End User (Pharmaceutical Companies, Biopharmaceutical Firms, CDMOs, Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Small Molecule API Market will witness a robust CAGR of 6.9%, valued at $203.4 billion in 2024 , and is expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:163 | $ 4485

Metastatic Lung Adenocarcinoma Treatment Market By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiotherapy, Combination Therapy); By Biomarker Status (EGFR Mutation, ALK Rearrangement, KRAS Mutation, PD-L1 Expression, Wild-Type); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Academic and Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Metastatic Lung Adenocarcinoma Treatment Market will witness a robust CAGR of 9.2% , valued at $12.4 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485

Neuroendocrine Tumor (NET) Treatment Market By Treatment Type (Somatostatin Analogs, Targeted Therapy, PRRT, Chemotherapy, Immunotherapy, Surgery); By Indication (GI NETs, Pancreatic NETs, Lung NETs, Others); By End User (Hospitals, Cancer Specialty Centers, Ambulatory Surgical Centers, Academic Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Neuroendocrine Tumor (NET) Treatment Market will witness a robust CAGR of 8.7% , value... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Gabapentin Market By Product Type (Generic, Branded); By Route of Administration (Oral Capsules/Tablets, Oral Solution, Others); By Indication (Epilepsy, Neuropathic Pain, Fibromyalgia, Off-Label Uses); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Gabapentin Market will witness a robust CAGR of 6.4% , valued at $2.87 billion in 2024 , and is expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Microbiology Culture Market By Type of Culture Media (Complex Media, Synthetic Media, Specialty Media, Enriched and Selective Media); By Application (Clinical Testing, Pharmaceutical Production, Food and Water Testing, Environmental Microbiology, Research); By End User (Hospitals & Labs, Biotech & Pharma Companies, Food Manufacturers, Research Institutes, Environmental Testing Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Microbiology Culture Market will witness a robust CAGR of 8.3% , valued at $5.3 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Drug Discovery Informatics Market By Solution Type (Software, Services); By Function (Sequence Analysis, Molecular Modeling, Docking, Target Data Analysis, Lead Optimization, Others); By Deployment Mode (On-premise, Cloud-Based); By End User (Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Drug Discovery Informatics Market will witness a robust CAGR of 12.3 %, valued at USD 5.36 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:168 | $ 4485

Herceptin Biosimilars Market By Product Type (Single-Agent, Combination-Ready, Lyophilized, Liquid); By Indication (HER2+ Breast Cancer, HER2+ Gastric Cancer); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Herceptin Biosimilars Market will witness a robust CAGR of 16.2%, valued at $1.84 billion in 2024 ... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Peptide Drug Conjugates Market By Product Type (Cytotoxic, Radiolabeled, Peptide-Oligonucleotide, Multivalent); By Application (Oncology, Autoimmune, Metabolic, Infectious, Neurological); By Route of Administration (IV, SC, IM, Oral); By End User (Hospitals, Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Peptide Drug Conjugates Market will witness a robust CAGR of 24.2% , valued at $1.73 billion in 2024 , expected to appreciate and reach $6.42 bill... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Inhalation Anesthesia Market By Product Type (Sevoflurane, Isoflurane, Desflurane, Nitrous Oxide); By Application (Maintenance Anesthesia, Induction Anesthesia, Sedation); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context


The Global Inhalation Anesthesia Market will witness a robust CAGR of 6.8%, valued at $2.4 billion in 2024, expected to appreciate and reach $3.99 billion by 2030, confirms Strategic Market Research.... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Automated NGS Library Preparation Market By Product Type (Automated Instruments, Reagents & Consumables, Software & Informatics Solutions); By Application (Oncology Research and Diagnostics, Genetic Disease and Rare Disorder Analysis, Infectious Disease Surveillance, Agrigenomics, Other Research Applications); By End User (Clinical Laboratories and Diagnostic Centers, Research Institutions and Academic Labs, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Agrigenomics and Food Safety Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Automated NGS Library Preparation Market will witness a robust CAGR of 13.2% , valued at approximately $970 million in 2024Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485

Transthyretin Amyloidosis Treatment Market By Drug Type (RNA Interference, Antisense Oligonucleotides, TTR Stabilizers, Supportive Therapies); By Route of Administration (Intravenous, Oral, Others); By End User (Hospitals & Specialty Clinics, Outpatient & Home Care, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Transthyretin Amyloidosis Treatment Market will witness a robust CAGR of 13.8% , valued at USD 2.1 billion in 2024, expe... Read More

Published Date: OCT-2025 | No Of Pages:168 | $ 4485

Non-Viral Transfection Reagents Market By Product Type (Lipid-Based, Polymer-Based, Protein-Based, Others); By Application (Gene Expression, RNAi, Genome Editing, Protein Production, Therapeutic Delivery); By End User (Pharma & Biotech, Academic Institutes, CROs, Clinical Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Non-Viral Transfection Reagents Market will witness a robust CAGR of 10.2% , valued at $1.1 billion in 2024 , and is expected to appreciate and reach $2.17 billion... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485

Aminoglycosides Market By Drug Type (Gentamicin, Amikacin, Tobramycin, Neomycin, Streptomycin, Others); By Route of Administration (Injectable, Topical, Oral); By Application (Human Health, Veterinary Health); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Aminoglycosides Market will witness a robust CAGR of 5.8% , valued at $1.24 billion in 2024 , and is expected to appreciate and reach $1.74 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Pharmaceutical Analytical Testing Outsourcing Market By Service Type (Bioanalytical Testing Services, Method Development and Validation, Stability Testing, Raw Material Testing, Microbiological Testing, Others); By End User (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, Academic and Research Institutes); By Molecule Type (Small Molecules, Large Molecules); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pharmaceutical Analytical Testing Outsourcing Market will witness a robust CAGR of 8.9% , valued at approximately $7.2 billionRead More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485

Infectious Disease Therapeutics Market By Product Type (Antiviral Drugs, Antibacterial Drugs, Antifungal and Antiparasitic Drugs, Monoclonal Antibodies and Immunotherapies); By Indication (HIV/AIDS, Hepatitis, Influenza, Tuberculosis, Malaria, Others); By Route of Administration (Oral, Parenteral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Infectious Disease Therapeutics Market will witness a robust CAGR of 7.4% , valued at approximately $145.6 billion in 2024 , and is expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Biopharmaceutical Manufacturing Consumables Testing Market By Testing Type (Sterility & Contamination Testing, Extractables and Leachables Testing, Particulate and Integrity Testing, Endotoxin and Pyrogen Testing, Functional Performance Testing); By Consumable Type (Single-Use Bioreactor Bags, Sterile Filters, Tubing & Connectors, Sampling Systems, Other Disposable Assemblies); By End User (Biopharmaceutical Manufacturers, CMOs, Academic & Research Institutes, Regulatory Testing Laboratories); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Biopharmaceutical Manufacturing Consumables Testing Market will witness a robust CAGR of 10.8%, valued at $4.2 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485

Dopamine Agonist Market By Product Type (Ergot-Derived, Non-Ergot); By Route of Administration (Oral, Transdermal, Injectable); By Indication (Parkinson’s Disease, Restless Leg Syndrome, Hyperprolactinemia, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dopamine Agonist Market will witness a robust CAGR of 6.5 % , valued at $3.4 billion in 2024 , expected to appreciate and reach $... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Forensic Genomics Market By Technology (Next-Generation Sequencing, Capillary Electrophoresis, PCR-Based Assays, Microarray-Based Genotyping); By Application (Criminal Casework, Missing Persons Identification, Disaster Victim Identification, Biodefense, Genealogical Research); By End User (Forensic Laboratories, Law Enforcement Agencies, Academic Institutions, Government Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Forensic Genomics Market will witness a robust CAGR of 13.7%, valued at $1.82 billion in 2024, expected to appreciate and reach $4.42 billion by 2030, con... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Tetanus Toxoid Vaccine Market By Product Type (Monovalent, Combination Vaccines); By Age Group (Pediatric, Adolescent & Adult); By Distribution Channel (Public Health Programs, Private Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tetanus Toxoid Vaccine Market will witness a robust CAGR of 5.5% , valued at approximately USD 2.4 billion in 2024 , and is expected to a... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Small Scale Bioreactors Market By Product Type (Single-Use Bioreactors, Stainless Steel Bioreactors); By Application (Process Development, Preclinical and Clinical Trials, Academic Research); By End User (Biopharmaceutical Companies, CDMOs, Academic and Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Small Scale Bioreactors Market will witness a robust CAGR of 12.4% (inferred), valued at $500 million in 2024, expected to appreciate and reach $2.5 billion by 2030, confirms Strategic Market Research.Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Sepsis Therapeutics Market By Drug Class (Antibiotics & Antimicrobials, Immunomodulators & Biologics, Adjuvant Therapies); By Pathogen Type (Gram-Negative Bacteria, Gram-Positive Bacteria, Fungal Infections); By Route of Administration (Intravenous, Oral); By End User (Hospitals & ICUs, Specialty Clinics & Research Institutions, Military & EMS); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sepsis Therapeutics Market will witness a robust CAGR of 8.4% , valued at $5.1 billion in 2024 , expected to appreciate and reach $8.3 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485

Dermatological Drugs Market By Drug Class (Corticosteroids, Retinoids, Anti-infectives, Calcineurin Inhibitors, Biologics, Others); By Indication (Acne, Psoriasis, Atopic Dermatitis, Rosacea, Skin Infections, Skin Cancer, Others); By Route of Administration (Topical, Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dermatological Drugs Market will witness a robust CAGR of 8.1%, valued at $27.6 billion in 2024, expected to appreciate and reach $46.3 billion ... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Viral Inactivation Market By Method Type (Solvent/Detergent Method, Low pH Treatment, UV Treatment, Pasteurization, Others); By Application (Blood and Plasma Products, Vaccines, Cell and Gene Therapy Products, Recombinant Proteins, Tissue & Stem Cell Products); By End User (Pharmaceutical & Biopharmaceutical Companies, CMOs/CROs, Academic & Research Institutions, Government & Regulatory Bodies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Viral Inactivation Market will witness a robust CAGR of 10.4 % , valued at $ 3.56 billion in 2024 , and... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Cell-Free Protein Expression Market By Product Type (Reagents, Expression Systems, Templates); By Application (Protein Engineering, High-Throughput Screening, Enzyme Engineering, Diagnostics, Synthetic Biology & Biomanufacturing); By End User (Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, CROs, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cell-Free Protein Expression Market will witness a robust CAGR of 7.8% , valued at $275.3 million in 2024 , and is expected to appreciate and reach $463.1 million ... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485

Cancer Stem Cells Market By Product Type (Targeted Therapies, Cell-Based Therapies, Others); By Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Other Cancers); By End User (Hospitals & Cancer Treatment Centers, Academic & Research Institutes, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Stem Cells Market will witness a robust CAGR of 7.92 % , valued at $1.6 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485

Cell Culture Vessels Market By Product Type (Cell Culture Flasks, Cell Culture Dishes and Plates, Roller Bottles, Bioreactors and Cell Culture Bags, Other Vessels); By Material (Polystyrene, Polycarbonate, Glass); By Application (Biopharmaceutical Production, Cell & Gene Therapy Manufacturing, Academic & Research Labs, Stem Cell Research, Tissue Engineering and Regenerative Medicine); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cell Culture Vessels Market will witness a robust CAGR of 7.8% , valued at USD 2.6 billion in 2024, expected to appreciate and reach USD 4.1 billi... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Polycystic Ovarian Syndrome (PCOS) Treatment Market By Drug Class (Hormonal Contraceptives, Insulin Sensitizers, Anti-Androgens, Fertility Agents, Others); By Route of Administration (Oral, Parenteral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Polycystic Ovarian Syndrome ( PCOS ) Treatment Market will witness a robust CAGR of 6.8% , valued at approximately $5.2 billionRead More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485

Urothelial Cancer Drugs Market By Drug Class (Immunotherapy Drugs, Chemotherapy Drugs, Targeted Therapies, Antibody-Drug Conjugates); By Route of Administration (Intravenous, Oral); By End User (Hospitals & Cancer Institutes, Specialty Clinics, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Urothelial Cancer Drugs Market will witness a robust CAGR of 10.2% , valued at $4.8 billion in 2024, expected to appreciate and reach $8.7 billion... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Alopecia Treatment Market By Product Type (Pharmaceuticals, Procedural Treatments, Cosmeceuticals & OTC Products); By Gender (Male, Female); By Distribution Channel (Dermatology Clinics & Hospitals, Aesthetic Clinics, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Alopecia Treatment Market will witness a robust CAGR of 6.8% , valued at $10.4 billion in 2024, expected to appreciate and reach $15.4 billionRead More

Published Date: OCT-2025 | No Of Pages:161 | $ 4485

Celiac Disease Treatment Market By Drug Class (Enzyme Therapies, Tight Junction Modulators, Immune Modulators, Medical Foods & Supplements); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Celiac Disease Treatment Market will witness a robust CAGR of 8.5% , valued at USD 1.35 billion in 2024 , expected to appreciate and reach USD 2.2... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Post-Traumatic Stress Disorder Treatment Market By Treatment Type (Pharmacological Therapy, Non-Pharmacological Therapy, Combination Therapy); By Therapeutic Class (SSRIs, Antipsychotics, Beta-Blockers, Benzodiazepines, Others); By End User (Hospitals & Clinics, Mental Health Institutions, Military & Veterans Affairs Facilities, Digital Therapy Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Post-Traumatic Stress Disorder ( PTSD ) Treatment Market will witness a robust CAGR of 6.9% , valued at $8.4 billion in 2024 , and is exp... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Non-Invasive Aesthetic Treatment Market By Procedure Type (Injectables, Laser and Light-Based, Radiofrequency, Ultrasound, Cryolipolysis, Others); By Gender (Male, Female, Non-Binary); By End User (Dermatology Clinics, Medi-Spas, Hospitals, Home Use); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Invasive Aesthetic Treatment Market will witness a robust CAGR of 11.08 % , valued at $ 17.9 billion in 2024 , expec... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485

Prostate Cancer Therapeutics Market By Therapy Type (Hormonal Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, Radiopharmaceuticals); By Stage (Localized, Advanced/Metastatic, Castration-Resistant); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Prostate Cancer Therapeutics Market will witness a robust CAGR of 9.8 % , valued at $17.8 billion in 2024 , and is expected to appreciate... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Point-of-Care Lipid Test Market By Product Type (Instruments/Analyzers, Consumables); By Technology (Biosensors, Spectrophotometry, Other Emerging Technologies); By End User (Hospitals and Clinics, Physician Offices and Diagnostic Centers, Retail Clinics and Pharmacies, Home Care Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Point-Of-Care Lipid Test Market will witness a robust CAGR of 7.4%, valued at approximately USD 985.3 million in 2024, expected to appreciate and reach around USD ... Read More

Published Date: OCT-2025 | No Of Pages:157 | $ 4485

Ulcerative Colitis Treatment Market By Drug Class (Aminosalicylates, Corticosteroids, Immunomodulators, Biologics, JAK Inhibitors, Others); By Disease Type (Mild, Moderate, Severe); By Route of Administration (Oral, Injectable, Rectal); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ulcerative Colitis Treatment Market is projected to witness a robust CAGR of 6.3% , valued at $7.9 billion in 2024 , and is expected to appreciate and reach $11.4 ... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485

Peptide Therapeutics Market By Type (Innovative Peptides, Generic Peptides); By Route of Administration (Parenteral, Oral, Others); By Application (Metabolic Disorders, Cancer, Cardiovascular Diseases, Infectious Diseases, Gastrointestinal Disorders, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peptide Therapeutics Market will witness a robust CAGR of 7.8% , valued at $ 32.2 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Dry Eye Syndrome Treatment Market By Product Type (Artificial Tears, Anti-Inflammatory Drugs, Secretagogues, Autologous Serum Eye Drops, Punctal Plugs, Devices); By Disease Type (Evaporative, Aqueous Deficient, Mixed); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dry Eye Syndrome Treatment Market will witness a robust CAGR of 8.4 % , valued at $ 7.5 billion in 2024 , and is ex... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Non-Small Cell Lung Cancer Therapeutics Market By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiotherapy & Others); By Route of Administration (Oral, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Small Cell Lung Cancer Therapeutics Market will witness a robust CAGR of 9.4% , valued at $23.8 billion in 2024 , expected to appreciate and reach $40.8 billio... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Senolytics and Anti-Aging Pharmaceuticals Market By Drug Class (Small Molecule Senolytics, Biologics, Peptides, Natural Compounds); By Mechanism of Action (Apoptotic Pathway Modulators, SASP Suppressors, DNA Repair Enhancers); By Application (Neurodegenerative Diseases, Osteoarthritis, Pulmonary Fibrosis, Cardiovascular, Dermatological); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Senolytics And Anti-Aging Pharmaceuticals Market will witness a robust CAGR of 17.2% , valued at $2.5 billion in 2024 , ... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Anticoagulants Market By Drug Type (Vitamin K Antagonists, Direct Oral Anticoagulants, Low Molecular Weight Heparin, Unfractionated Heparin, Other Parenteral Anticoagulants); By Route of Administration (Oral, Injectable); By Application (Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism, Ischemic Stroke, Surgical Thromboprophylaxis); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anticoagulants Market will witness a robust CAGR of 5.6 % , valued at $41.3 billion in 2024 , expected to appreciate and reach $<... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Acute Myeloid Leukemia Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation, Others); By Route of Administration (Oral, Injectable); By End User (Hospitals, Specialty Cancer Clinics, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acute Myeloid Leukemia Treatment Market will witness a strong CAGR of 11.2 %, valued at $ 5.3Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Atopic Dermatitis Clinical Trials Market By Trial Phase (Phase I, Phase II, Phase III, Phase IV); By Molecule Type (Biologics, Small Molecules, Topical Agents, Natural/Herbal Compounds); By Sponsor Type (Pharmaceutical & Biotech Companies, Academic & Research Institutions, Hospitals & Clinics, Government & Nonprofit Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Atopic Dermatitis Clinical Trials Market will witness a robust CAGR of 6.8% , valued at $1.42 billion in 2024 , expected to appreciate and reach $2.11 billion... Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485

Cell Therapy Human Raw Materials Market By Material Type (Growth Factors, Cytokines, Serum, Media, Enzymes, Scaffolds); By Therapy Type (Allogeneic, Autologous, Stem Cell, CAR-T); By End User (Biopharma, CDMOs, Academic, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cell Therapy Human Raw Materials Market will witness a robust CAGR of 12.7% , valued at $3.2 billion in 2024 , expected to appreciate and reach $7.4 billion b... Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485

Serum-Free Media Market By Product Type (Protein-Free, Chemically Defined, Xeno-Free, Custom/Modified Media); By Application (Biopharmaceutical Production, Regenerative Medicine & Cell Therapy, Cancer Research, Toxicity Testing, Tissue Engineering, Others); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs, CDMOs, Hospitals & Clinical Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Serum-Free Media Market will witness a robust CAGR of 10.3% , valued at USD 3.5 billion in 2024 , and is expected to appreciate and reach... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Microbiome Therapeutics Market By Product Type (Live Biotherapeutic Products, Prebiotics & Postbiotics, Fecal Microbiota Transplantation); By Application (Gastrointestinal Disorders, Oncology, Metabolic Diseases, Neurological Disorders, Autoimmune Conditions); By Route of Administration (Oral, Rectal, Enteric-Coated, Others); By End User (Hospitals, Academic Institutions, Biotech Companies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Microbiome Therapeutics Market will witness a robust CAGR of 31.8% , valued at $1.67 billion in 2024 , and is expected to appreciate and reach $10.83 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:186 | $ 4485

Duodenal Ulcer Treatment Market By Drug Class (Proton Pump Inhibitors, H2 Receptor Antagonists, Antibiotics, Protective Agents); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Duodenal Ulcer Treatment Market will witness a robust CAGR of 7.2 % valued at USD 4.3 billion in 2024 , expected to appreciate and reach USD 6.1 b... Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485

Cerebral Infarction Treatment Market By Treatment Type (Pharmacological Interventions [Thrombolytics, Antiplatelet Agents, Anticoagulants, Neuroprotective Agents], Surgical Procedures [Mechanical Thrombectomy, Carotid Endarterectomy, Decompressive Hemicraniectomy], Supportive and Adjunctive Care); By Mode of Administration (Intravenous, Oral, Intra-Arterial); By End User (Hospitals and Stroke Centers, Ambulatory Surgical Centers, Specialty Neurology Clinics, Rehabilitation Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cerebral Infarction Treatment Market will witness a robust CAGR of 9.35 % , valued at approximately USD 9.4 billion in 2024 , expected to... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Acinetobacter Pneumonia Therapeutics Market By Drug Class (β-lactams, Polymyxins, Carbapenems, Sulbactam Combinations, Novel Agents); By Route of Administration (Intravenous, Oral, Inhalation); By End User (Hospitals, ICUs, ASCs, Military Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acinetobacter Pneumonia Therapeutics Market will witness a promising CAGR of 7.6% , valued at $1.12 billion in 2024 , and is projected to... Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Spinal Muscular Atrophy (SMA) Treatment Market By Treatment Type (Gene Therapy, Antisense Oligonucleotides, Small Molecule Drugs, Supportive Therapy); By Disease Type (Type I, Type II, Type III, Type IV); By Route of Administration (Intrathecal, Intravenous, Oral); By End User (Hospitals & Clinics, Homecare Settings, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Spinal Muscular Atrophy ( SMA ) Treatment Market will witness a robust CAGR of 13.2 %, valued at $2.14 bill... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Uveitis Treatment Market By Drug Class (Corticosteroids, Immunosuppressive Agents, Biologics, Cycloplegics, Antimicrobials); By Disease Type (Anterior, Intermediate, Posterior, Panuveitis); By Route of Administration (Topical, Oral, Injectable, Implants); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Uveitis Treatment Market will witness a robust CAGR of 6.8% , valued at $812.4 million in 2024 , expected to appreciate and reach $1.21 billion by 2030 , ... Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485

Rosacea Treatment Market By Treatment Type (Topical Medications, Oral Antibiotics, Laser & Light Therapies, Biologics & Others, Cosmeceuticals & OTC); By Route of Administration (Topical, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Aesthetic Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rosacea Treatment Market will witness a robust CAGR of 5.6 % , valued at $ 2.36 billion in 2024 , and i... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Sterile Bioprocess Filtration Market By Product Type (Membrane Filters, Cartridge & Capsule Filters, Single-Use Filters & Assemblies, Depth Filters, Other Accessories & Systems); By Application (Cell Culture Media Filtration, Buffer & Intermediate Filtration, Virus Removal/Filtration, Final Fill/Finish Filtration, Others); By End User (Biopharmaceutical & Biotechnology Companies, Contract Manufacturing Organizations, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sterile Bioprocess Filtration Market will witness a robust CAGR of 8.9% , valued at approximately USD 7.8 billion in 2024, and is expected to appreciate a... Read More

Published Date: OCT-2025 | No Of Pages:179 | $ 4485

Stroke Management Market By Product Type (Diagnostics, Therapeutic Devices, Medications, Rehabilitation Solutions); By Application (Ischemic Stroke, Hemorrhagic Stroke, Transient Ischemic Attack); By End User (Hospitals & Stroke Centers, ASCs, Rehabilitation Facilities, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stroke Management Market will witness a robust CAGR of 6.4% , valued at USD 31.5 billion in 2024 , expected to appreciate and reach USD 48.43Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Cell Culture Vitamins Market By Type (Water-Soluble Vitamins, Fat-Soluble Vitamins); By Formulation (Single Vitamins, Multivitamin Blends, Customized Vitamin Mixtures); By Application (Biopharmaceutical Production, Academic & Industrial Research, Stem Cell Therapy, Vaccine Development, Tissue Engineering); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cell Culture Vitamins Market will witness a robust CAGR of 8.7% , valued at $536.4 million in 2024 , and is expected to appreciate and reach $943.1 million by 2030... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Stomach Cancer Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery); By Cancer Type (Adenocarcinoma, Gastrointestinal Stromal Tumor, Lymphoma, Carcinoid Tumors); By End User (Hospitals, Specialty Cancer Clinics, Academic Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stomach Cancer Treatment Market will witness a robust CAGR of 7.2% , valued at USD 6.8 billion in 2024 , and is expected to appreciate and reach USD 10.4 billion b... Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Nucleic Acid Methylation Market By Product Type (Reagents & Kits, Instruments & Platforms, Software & Services); By Technology (PCR, HRM, Microarray, NGS, Nanopore Sequencing); By Application (Oncology, Neurodegenerative Disorders, Autoimmune Diseases, Prenatal Screening, Agrigenomics); By End User (Academic & Research Institutes, Pharmaceutical & Biotech Companies, Clinical Labs, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nucleic Acid Methylation Market will witness a robust CAGR of 13.2% , valued at $1.45 billion in 2024 , and is expected to appreciate and reach $3.08 billion ... Read More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485

In-Vitro Toxicology Assays Market By Assay Type (Cell Viability, Genotoxicity, Cytotoxicity, Others); By Technology (High-Throughput Screening, Cell Culture Technologies, Omics-Based Approaches, Molecular Imaging); By Application (Pharmaceutical Development, Cosmetics Testing, Chemical Safety Evaluation, Food Safety Assessment); By End User (Pharmaceutical & Biotechnology Companies, CROs, Academic & Research Institutes, Regulatory Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global In-Vitro Toxicology Assays Market will witness a robust CAGR of 7.82 % , valued at $4.6 billion in 2024 , expected to appreciate and reac... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Prediabetes Market By Product Type (Diagnostic Solutions, Pharmacologic Treatments, Digital Therapeutics & Lifestyle Programs, Nutraceuticals); By Application (Screening & Risk Stratification, Disease Management & Prevention, Patient Engagement & Adherence Support); By End User (Hospitals & Specialty Clinics, Primary Care Settings, Homecare & Self-Testing, Employer & Community Health Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

INTRODUCTION AND STRATEGIC CONTEXT

The Global Prediabetes Market will witness a robust CAGR of 8.6%, valued at $140.2 billion in 2024, expected to appreciate and reach $229.7 billion by 2030, confirms Strategic Market Research.

&nbs... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Peanut Allergy Treatment Market By Treatment Type (Immunotherapy [Oral, Epicutaneous, Sublingual], Biologic Therapy [Anti-IgE, Anti-IL Agents], Emergency Medication, Adjunct Therapy); By Route of Administration (Oral, Epicutaneous, Injectable, Sublingual); By Age Group (Pediatric, Adolescents, Adults); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Peanut Allergy Treatment Market will witness a robust CAGR of 10.7% , valued at USD 680 million in 2024 , expected to appreciate and reach USD 1.25 billion by 2030... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

Onychomycosis Treatment Market By Treatment Type (Topical, Oral, Laser, Combination); By Infection Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Total Dystrophic); By Drug Type (Prescription, OTC, Natural Remedies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Onychomycosis Treatment Market will witness a robust CAGR of 7.8% , valued at $ 3.5 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Aseptic Connectors Market By Type (Single-Use, Reusable); By Connection Design (Gendered, Genderless); By End User (Biopharmaceutical Companies, CDMOs, Academic & Research Institutes, Food & Beverage Manufacturers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aseptic Connectors Market will witness a robust CAGR of 8.4% , valued at USD 1.1 billion in 2024 , and is expected to appreciate and reach USD 1.9 billion by 2030<... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Intravenous Immunoglobulin Market By Product Type (Lyophilized, Liquid); By Therapeutic Indication (Primary Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy, Immune Thrombocytopenic Purpura, Guillain–Barré Syndrome, Others); By End User (Hospitals, Specialty Clinics & Infusion Centers, Home Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Intravenous Immunoglobulin ( IVIG ) Market will witness a robust CAGR of 7.8% , valued at approximately $15.6 billion in... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Myasthenia Gravis Treatment Market By Treatment Type (Medication-Based Therapy, Monoclonal Antibodies, Plasma-Based Therapies, Surgical Intervention); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics & Infusion Centers, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Myasthenia Gravis Treatment Market will witness a robust CAGR of 7.1% , valued at $1.46 billion in 2024 , and is expected to appreciate and reach $2.35 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

NGS-Based RNA-Sequencing Market By Technology (Sequencing by Synthesis, Nanopore Sequencing, Others); By Application (Transcriptome Profiling, Differential Gene Expression Analysis, Fusion Gene Detection, Small RNA Sequencing, Others); By End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinical Laboratories, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global NGS -Based RNA -Sequencing Market will witness a robust CAGR of 15.7% , valued at USD 4.85 billion in <... Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Cellular Rejuvenation Therapeutics Market By Therapy Type (Gene Therapy & Epigenetic Reprogramming, Senolytic Therapies, Stem Cell-Based Therapies, Exosome and Extracellular Vesicle Therapies); By Application (Neurodegenerative Diseases, Ophthalmology, Dermatology & Aesthetics, Musculoskeletal Disorders, Cardiovascular and Metabolic Disorders); By Delivery Mechanism (Systemic, Localized, Genetic Delivery); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Cellular Rejuvenation Therapeutics Market is poised for a transformative run, advancing at a CAGR of 19.6%, with a valuation of USD 1.34 billion in 2024, expected to re... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Extracellular Vesicle (EV) Surface Antigen Targeting and EV Trap Market By Technology Type (EV Surface Antigen Targeting Platforms, EV Trapping Agents, Microfluidic EV Isolation Systems, Magnetic and Affinity-Based Capture Kits, EV Depletion Therapies); By Application (Oncology, Neurology, Autoimmune Diseases, Infectious Diseases, Regenerative Medicine & Cell Therapy Monitoring); By End User (Research Institutions & Academic Labs, Biotechnology & Pharmaceutical Companies, Diagnostic Companies & Clinical Labs, Hospitals & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Extracellular Vesicle (EV) Surface Antigen Targeting and EV Trap Market will witness a CAGR of 13.5%, valued at USD 412.7 million in 2024, and projected to reach Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Organoid-Based Therapeutic Implants Market By Organoid Type (Liver Organoids, Retinal Organoids, Intestinal Organoids, Pancreatic Organoids); By Application (Ophthalmology, Hepatology, Gastroenterology, Endocrinology, Nephrology); By End User (Academic Medical Centers, Tertiary Hospitals, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Organoid-Based Therapeutic Implants Market is on track to grow at a CAGR of 27.8%, reaching USD 1.36 billion by 2030, up from an estimated USD 312.5 million in ... Read More

Published Date: Oct-2025 | No Of Pages:191 | $ 4485

Psoriasis Treatment Market By Drug Class (Biologics, Topical Therapies, Systemic Non-biologics, Biosimilars); By Route of Administration (Injectable, Oral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Psoriasis Treatment Market will witness a robust CAGR of 8.1% , valued at USD 32.5 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Precision Genomic Testing Market By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Microarrays, In Situ Hybridization, Others); By Application (Oncology, Rare and Inherited Diseases, Pharmacogenomics, Neurology, Reproductive Health, Others); By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutions, Biopharmaceutical Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Precision Genomic Testing Market will witness a robust CAGR of 13.7%, valued at $5.2 billion in 2024 , expected to appreciate and reach $11.2 billion by 2030<... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485

Androgenetic Alopecia Market By Product Type (Oral Pharmaceuticals, Topical Solutions, Hair Transplant Devices & Procedures, Regenerative Therapies, Cosmetic Camouflaging Products); By Gender (Male, Female); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Androgenetic Alopecia Market will witness a robust CAGR of 6.8% , valued at approximately $8.4 billion in 2024 , expecte... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Osteoporosis Drugs Market By Drug Class (Bisphosphonates, SERMs, Parathyroid Hormone Analogs, RANK Ligand Inhibitors, Calcitonin & Others); By Route of Administration (Oral, Injectable); By End User (Hospitals & Specialty Clinics, Retail Pharmacies, Online Pharmacies, Long-Term Care Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Osteoporosis Drugs Market will witness a robust CAGR of 5.8% , valued at $7.69 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Invasive Ductal Carcinoma Treatment Market By Treatment Type (Surgery, Chemotherapy, Radiation Therapy, Hormonal Therapy, Targeted Therapy, Immunotherapy); By Therapy Modality (Monotherapy, Combination Therapy, Adjuvant Therapy, Neoadjuvant Therapy); By End User (Hospitals, Cancer Specialty Clinics, ASCs, Academic and Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Invasive Ductal Carcinoma Treatment Market will witness a robust CAGR of 7.9% , valued at $17.6 billion in 2024 , expected to appreciate and reach $27.8 billion by... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Whole Genome Bisulfite Sequencing Market By Offering (Products, Services); By Application (Cancer Research, Neurodevelopmental Disorders, Aging, Autoimmune Diseases); By End User (Academic Institutes, Pharma & Biotech Companies, Clinical Labs, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Whole Genome Bisulfite Sequencing (WGBS) Market will witness a robust CAGR of 18.3%, valued at $785.6 milli... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Duchenne Muscular Dystrophy Treatment Market By Therapy Type (Corticosteroids, Exon-Skipping Therapies, Gene Therapy, Others); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Duchenne Muscular Dystrophy (DMD) Treatment Market will witness a robust CAGR of 13.8% , valued at $Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Nasal Spray Market By Product Type (Decongestant Nasal Sprays, Steroid Nasal Sprays, Saline Nasal Sprays, Antihistamine Nasal Sprays, Other Nasal Sprays); By Application (Allergic Rhinitis, Sinusitis, Common Cold & Congestion, Nasal Polyps, Migraine & Neurological Treatments, Vaccination); By End User (Hospitals & Clinics, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nasal Spray Market will witness a robust CAGR of 6.8% , valued at approximately USD 14.3 billion in 2024, and is expected to appreciate a... Read More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485

DNA Synthesis Market By Product Type (Oligonucleotide Synthesis, Gene Synthesis, Custom Libraries, Consumables & Reagents); By Application (Therapeutics Development, Diagnostics, Synthetic Biology, Academic Research); By End User (Biotechnology Companies, Pharmaceutical Companies, Academic & Research Institutions, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DNA Synthesis Market will witness a robust CAGR of 14.43 % , valued at $2.78 b... Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485

Systemic Lupus Erythematosus Treatment Market By Drug Class (Antimalarials, NSAIDs, Corticosteroids, Immunosuppressants, Biologics and Targeted Therapies); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Systemic Lupus Erythematosus Treatment Market will witness a robust CAGR of 7.9% , valued at $3.65 billion in 2024, expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

GLP-1 Receptor Agonists Market By Product Type (Injectable GLP-1 Receptor Agonists, Oral GLP-1 Receptor Agonists); By Indication (Type 2 Diabetes Mellitus, Obesity and Weight Management); By Route of Administration (Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global GLP -1 Receptor Agonists Market will witness a robust CAGR of 12.3% , valued at $18.4 billion in 2024 , expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Pharmaceutical Lipids Market By Product Type (Triglycerides, Phospholipids, Sphingolipids, Sterols); By Application (Drug Delivery Systems, Vaccines, Nutraceuticals); By Form (Liquid, Solid); By End User (Pharmaceutical Companies, Biotechnology Firms, CMOs, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Lipids Market will witness a robust CAGR of 10.23 % , valued at $6.3 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Chemotherapy-Induced Neutropenia Treatment Market By Product Type (G-CSFs, Biosimilars, Antibiotics & Antifungals, Others); By Route of Administration (Subcutaneous, Intravenous, Oral); By End User (Hospitals, Oncology Clinics, Homecare Settings, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chemotherapy-Induced Neutropenia (CIN) Treatment Market will witness a robust CAGR of 6.8%, valued at $12.3 billion in 2024 , and is expe... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Epithelioma Treatment Market By Treatment Type (Surgical Intervention, Radiation Therapy, Chemotherapy, Immunotherapy & Targeted Therapy, Photodynamic Therapy); By Cancer Type (Basal Cell Carcinoma, Squamous Cell Carcinoma, Transitional Cell Carcinoma, Other Rare Epitheliomas); By Route of Administration (Oral, Intravenous, Topical, Intralesional); By End User (Hospitals & Specialty Cancer Centers, Ambulatory Surgical Centers, Dermatology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Epithelioma Treatment Market will witness a robust CAGR of 9.1% , valued at USD 2.1 billion in 2024, ex... Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Respiratory Disease Vaccine Market By Vaccine Type (Live Attenuated, Inactivated, Subunit/Recombinant/Polysaccharide/Conjugate, mRNA); By Disease Indication (Influenza, COVID-19, RSV, Pneumococcal, Others); By Route of Administration (Injectable, Intranasal); By Age Group (Pediatric, Adult, Geriatric); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Respiratory Disease Vaccine Market will witness a robust CAGR of 8.2% , valued at $24.7 billion in 2024 , expected to ap... Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Opioid Use Disorder Treatment Market By Product Type (Medication-Assisted Treatment, Behavioral Therapy & Counseling, Digital Therapeutics); By Route of Administration (Oral, Sublingual, Injectable); By Treatment Setting (Outpatient, Residential/Inpatient, Telehealth); By Distribution Channel (Specialized Opioid Treatment Programs, Hospitals & Clinics, Retail Pharmacies, Online Pharmacies & Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Opioid Use DisorderTreatment Market will witness a robust CAGR of 7.3% , valued at $5.4 billion in 2024, expected to app... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Pruritus Therapeutics Market By Drug Class (Antihistamines, Corticosteroids, Calcineurin Inhibitors, Opioid Receptor Modulators, Biologic Therapies); By Route of Administration (Topical, Oral, Injectable); By Disease Type (Atopic Dermatitis, Chronic Kidney Disease–Associated Pruritus, Psoriasis, Cholestatic Pruritus, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pruritus Therapeutics Market will witness a robust CAGR of 5.8% , valued at $7.4 billion in 2024 , expected to appreciate and reach $10.4 billion by 2030 ... Read More

Published Date: OCT-2025 | No Of Pages:169 | $ 4485

Self-Amplifying RNA (saRNA) Synthesis Market By Product Type (IVT Enzymes and Kits, Purification and Cleanup Products, Custom Synthesis Services, Analytical Testing & QC Solutions); By Application (Vaccines, Cancer Therapeutics, Gene Therapy and Protein Replacement, Research and Development); By End User (Biopharmaceutical Companies, CDMOs, Academic and Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Self-Amplifying RNA Synthesis Market will witness a robust CAGR of 36.7% , valued at $268 million in 2024 , and is expec... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Schizophrenia Drugs Market By Drug Class (Second-Generation Antipsychotics, First-Generation Antipsychotics, Adjunctive Therapies); By Route of Administration (Oral, Long-Acting Injectables, Others); By Treatment Phase (Acute, Maintenance, Treatment-Resistant); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Schizophrenia Drugs Market will witness a robust CAGR of 5.9% , valued at $8.4 billion in 2024 , and is expected to appreciate and reach $ 10.82Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485

Automated Microbiology Market By Product Type (Instruments, Software & Informatics, Reagents & Consumables); By Application (Clinical Diagnosis, Pharmaceutical Microbiology, Food & Beverage Testing, Environmental Microbiology); By End User (Hospitals & Clinical Labs, Pharmaceutical & Biotechnology Companies, Food Manufacturers, Environmental Agencies, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Automated Microbiology Market will witness a robust CAGR of 9.8%, valued at $8.6 billion in 2024 , and is expected to appreciat... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Hearing Loss Disease Treatment Market By Treatment Type (Devices, Pharmaceuticals, Surgery, Gene & Cell Therapies); By Hearing Loss Type (Sensorineural, Conductive, Mixed); By End User (Hospitals & ENT Clinics, Ambulatory Surgical Centers, Hearing Aid Retail Chains, Teleaudiology Platforms, Academic & Research Institutes); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hearing Loss Disease Treatment Market will witness a robust CAGR of 8.4 %, valued at $13.4 billion in 2024 , and is expected to appreciat... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Multiple Sclerosis Therapeutics Market By Drug Class (Immunomodulators, Oral Agents, Monoclonal Antibodies, Others); By Route of Administration (Oral, Injectable, Intravenous Infusion); By Disease Type (Relapsing-Remitting MS, Secondary Progressive MS, Primary Progressive MS); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Multiple Sclerosis Therapeutics Market will witness a robust CAGR of 6.8% , valued at approximately $28.7 billion in 2024 , expected to appreciate and rea... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Atopic Dermatitis Drugs Market By Drug Type (Biologics, Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Antihistamines, Others); By Route of Administration (Topical, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Atopic Dermatitis Drugs Market will witness a robust CAGR of 10.2% , valued at USD 6.8 billion in 2024 , and is expected to appreciate and reach USD 13.5 billion b... Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485

Microsclerotherapy Treatment Market By Treatment Type (Liquid Microsclerotherapy, Foam-Based Microsclerotherapy); By Vein Location (Lower Limb Veins, Facial/Upper Body Veins); By End User (Dermatology Clinics, Aesthetic Clinics & Medspas, Ambulatory Surgical Centers, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Microsclerotherapy Treatment Market will grow at a steady CAGR Of 5.8% , reaching a projected value of USD 111.3 Million By 2030 , up fro... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485

Remote Endarterectomy Devices Market By Product Type (Ring Dissectors, Endarterectomy Catheters, Vessel Snares); By Application (Chronic Total Occlusions, Critical Limb Ischemia, Long-Segment SFA Disease); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Vascular Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Remote Endarterectomy Devices Market will witness a steady CAGR Of 6.7%, valued at around USD 412 Million In 2024 , and projected to reach approximately USD 610 Mi... Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Prostaglandin Analogs Market By Product Type (Latanoprost, Bimatoprost, Travoprost, Tafluprost, Misoprostol, Dinoprostone, Carboprost); By Application (Glaucoma and Ocular Hypertension, Reproductive Health, Gastric Ulcer Prevention, Erectile Dysfunction, Pulmonary Arterial Hypertension); By Route of Administration (Topical, Oral, Vaginal, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, NGO/Government Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Prostaglandin Analogs Market will grow at a steady CAGR Of 6.1%, valued at USD 3.2 Billion In 2024 , and is projected to reach nearly USD 4.6 Billion By 2030,Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485

Electronic Lab Notebook Market By Type (Cross-Disciplinary ELNs, Domain-Specific ELNs); By Deployment (Cloud-Based, On-Premise); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutes, CROs & CDMOs, Chemical & Material Science Labs, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Electronic Lab Notebook Market is projected to grow at a CAGR Of 8.5%, valued at 790 Million USD In 2024 , and expected to cross 1.3 Billion USD By 2030 ,... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Long-Acting Beta-Agonists Market By Drug Type (Formoterol, Salmeterol, Indacaterol, Olodaterol, Others); By Combination Class (LABA Monotherapy, LABA + ICS, LABA + LAMA, LABA + ICS + LAMA); By Indication (Asthma, COPD, Others); By Route of Administration (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Long-Acting Beta-Agonists (LABA) Market is forecast to grow at a CAGR Of 6.1% , reaching USD 5.6 Billion By 2030 , up from USD 3.9 Billion In 2024 , accor... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485